Literature DB >> 21364231

Treatment options for chronic rhinosinusitis.

Jeffrey D Suh1, David W Kennedy.   

Abstract

Chronic rhinosinusitis (CRS) is defined as persistent symptomatic inflammation of the nasal and sinus mucosa. Although insights into the pathophysiology of CRS have largely expanded over the last 2 decades, the exact etiology is still unknown and is likely due to multiple host and environmental factors. Treatments are aimed at reducing mucosal inflammation, controlling infection, and restoring mucociliary clearance within the sinuses. The principal goal of this article is to outline a rational approach to the treatment of chronic sinus disease on the basis of currently available diagnostic and therapeutic techniques. Emphasis will be placed on the management, therapeutic response, and objective evaluation of therapeutic efficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21364231     DOI: 10.1513/pats.201003-028RN

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  12 in total

1.  A survey on chronic rhinosinusitis: opinions from experts of 50 countries.

Authors:  Desiderio Passali; Cemal Cingi; Jacopo Cambi; Francesco Passali; Nuray Bayar Muluk; Maria Luisa Bellussi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-07       Impact factor: 2.503

2.  Antihistamine use and immunoglobulin E levels in glioma risk and prognosis.

Authors:  E Susan Amirian; Deborah Marquez-Do; Melissa L Bondy; Michael E Scheurer
Journal:  Cancer Epidemiol       Date:  2013-08-30       Impact factor: 2.984

3.  Intranasal Delivery of Topically-Acting Levofloxacin to Rats: a Proof-of-Concept Pharmacokinetic Study.

Authors:  Joana Sousa; Gilberto Alves; Ana Fortuna; Amílcar Falcão
Journal:  Pharm Res       Date:  2017-07-26       Impact factor: 4.200

4.  Prevention of sinonasal inflammation by a synthetic glycosaminoglycan.

Authors:  Abigail Pulsipher; Xuan Qin; Andrew J Thomas; Glenn D Prestwich; Siam Oottamasathien; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2016-11-11       Impact factor: 3.858

5.  The impact of Sambucus nigra L. extract on inflammation, oxidative stress and tissue remodeling in a rat model of lipopolysaccharide-induced subacute rhinosinusitis.

Authors:  C N Tiboc Schnell; Gabriela Adriana Filip; N Decea; R Moldovan; R Opris; S C Man; B Moldovan; L David; F Tabaran; D Olteanu; A M Gheldiu; I Baldea
Journal:  Inflammopharmacology       Date:  2021-04-21       Impact factor: 4.473

6.  Cytotoxic T lymphocytes mediate chronic inflammation of the nasal mucosa of patients with atypical allergic rhinitis.

Authors:  Shuqi Qiu; Yun Du; Xiaobei Duan; Xiaorui Geng; Jianxiong Xie; Han Gao; Ping-Chang Yang
Journal:  N Am J Med Sci       Date:  2011-08

7.  MicroRNA-761 suppresses remodeling of nasal mucosa and epithelial-mesenchymal transition in mice with chronic rhinosinusitis through LCN2.

Authors:  Jinzhang Cheng; Junjun Chen; Yin Zhao; Jingpu Yang; Kai Xue; Zonggui Wang
Journal:  Stem Cell Res Ther       Date:  2020-04-09       Impact factor: 6.832

8.  Exacerbations of Chronic Rhinosinusitis-Microbiology and Perspectives of Phage Therapy.

Authors:  Joanna Szaleniec; Agnieszka Gibała; Monika Pobiega; Sylwia Parasion; Jacek Składzień; Paweł Stręk; Tomasz Gosiewski; Maciej Szaleniec
Journal:  Antibiotics (Basel)       Date:  2019-10-05

9.  The Therapeutic Effect of 1,8-Cineol on Pathogenic Bacteria Species Present in Chronic Rhinosinusitis.

Authors:  Matthias Schürmann; Felix Oppel; Martin Gottschalk; Björn Büker; Christian Andreas Jantos; Cornelius Knabbe; Andreas Hütten; Barbara Kaltschmidt; Christian Kaltschmidt; Holger Sudhoff
Journal:  Front Microbiol       Date:  2019-10-22       Impact factor: 5.640

10.  Intra-oral low level laser therapy in chronic maxillary sinusitis: A new and effective recommended technique.

Authors:  Hamed Mortazavi; Hamidreza Khalighi; Ali Goljanian; Robab Noormohammadi; Saeed Mojahedi; Siamak Sabour
Journal:  J Clin Exp Dent       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.